Single-photon emission computed tomography (SPECT)
Showing 1 - 25 of >10,000
Biochemically Recurrent Prostate Carcinoma, Prostate Adenocarcinoma Trial in Atlanta (procedure, radiation, other, drug)
Not yet recruiting
- Biochemically Recurrent Prostate Carcinoma
- Prostate Adenocarcinoma
- Biospecimen Collection
- +6 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Oct 25, 2023
Radioiodine Planar andSPECT/CT Imaging With Iodine-123 for
Recruiting
- Thyroid Gland Follicular Carcinoma
- Computed Tomography
- +3 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 4, 2023
Single Photon Emission Computed Tomography/Computed Tomography
Not yet recruiting
- Brain Glioma
- SPECT with pentavalent 99mTc DMSA
- (no location specified)
Oct 23, 2022
Melanoma (Skin), Melanoma Stage IV, Melanoma, Uveal Trial in Rochester ([203Pb]VMT01, [68Ga]VMT02)
Recruiting
- Melanoma (Skin)
- +3 more
-
Rochester, MinnesotaMayo Clinic
Aug 5, 2022
Prostate Carcinoma, Recurrent Prostate Carcinoma Trial in Los Angeles (99mTc-based PSMA Imaging and Surgery Agent, Computed
Recruiting
- Prostate Carcinoma
- Recurrent Prostate Carcinoma
- 99mTc-based PSMA Imaging and Surgery Agent
- +2 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Jul 21, 2022
Neuroendocrine Tumors, Somatostatin Receptor-positive Neuroendocrine Tumor Trial in Madison (Single Photon Emission Computed
Not yet recruiting
- Neuroendocrine Tumors
- Somatostatin Receptor-positive Neuroendocrine Tumor
- Single Photon Emission Computed Tomography/ Computed Tomography (SPECT/CT)
- +3 more
-
Madison, WisconsinUniversity of Wisconsin - Madison
Nov 2, 2023
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Seattle
Not yet recruiting
- Castration-Resistant Prostate Carcinoma
- +2 more
- Biopsy
- +9 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Nov 17, 2023
Metastatic Liver Carcinoma, Stage IV Liver Cancer, Stage IVA Liver Cancer Trial in Houston (procedure, radiation, other)
Active, not recruiting
- Metastatic Liver Carcinoma
- +3 more
- Angiography
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Sep 22, 2022
Stage IIB Lung Non-Small Cell Carcinoma AJCC v7, Stage IIIA Lung Non-Small Cell Cancer AJCC v7, Stage IIIB Lung Non-Small Cell
Active, not recruiting
- Stage IIB Lung Non-Small Cell Carcinoma AJCC v7
- +2 more
- Computed Tomography
- +7 more
-
Seattle, Washington
- +1 more
Jul 18, 2022
Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, Stage IV Liver Cancer Trial in Seattle (Computed Tomography, Single
Recruiting
- Hepatocellular Carcinoma
- +5 more
- Computed Tomography
- +2 more
-
Seattle, Washington
- +1 more
Feb 24, 2022
Metastatic Malignant Peripheral Nerve Sheath Tumor, Neurofibromatosis Type 1, Recurrent Malignant Peripheral Nerve Sheath Tumor
Recruiting
- Metastatic Malignant Peripheral Nerve Sheath Tumor
- +2 more
- Computed Tomography
- +4 more
-
Rochester, MinnesotaMayo Clinic
Jul 6, 2022
Dementia, Parkinsonism, Mild Cognitive Impairment Trial in Rochester (I-123 Ioflupane solution injection prior to SPECT scan
Enrolling by invitation
- Dementia
- +3 more
- I-123 Ioflupane solution injection prior to SPECT scan (DaTscan)
- Single photon emission computed tomography (SPECT) scan
-
Rochester, MinnesotaMayo Clinic
Apr 25, 2022
Endometrial Cancer Trial in Stanford (Lymphoseek, Single Photon Emission Computed Tomography (SPECT), Indocyanine Green (ICG))
Suspended
- Endometrial Cancer
- Lymphoseek
- +3 more
-
Stanford, CaliforniaStanford University, School of Medicine
Jun 13, 2022
Locally Advanced Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8 Trial in Houston
Recruiting
- Locally Advanced Lung Non-Small Cell Carcinoma
- +4 more
- 6 Minute Walk Functional Test
- +6 more
-
Houston, TexasM D Anderson Cancer Center
May 13, 2022
Correlation Between SPECT/CT and IDH Mutation in Brain Glioma
Not yet recruiting
- Brain Glioma
- (no location specified)
Oct 23, 2022
Ventilation Homogeneity asMarker of Small Airway Disease in
Recruiting
- Lung Function Testing
- +4 more
- SPECT/CT
-
Montréal, Quebec, CanadaCentre Hospitalier de l'Université de Montréal (CHUM)
Aug 3, 2021
Metastatic Colorectal Carcinoma, Metastatic Malignant Tumor in the Liver, Stage IV Colorectal Cancer AJCC v8 Trial (biological,
Not yet recruiting
- Metastatic Colorectal Carcinoma
- +3 more
- Bevacizumab
- +11 more
- (no location specified)
May 9, 2023
Primary Malignant Liver Tumor Trial in Palo Alto (procedure, device, diagnostic test)
Completed
- Primary Malignant Liver Neoplasm
- Computed Tomography (CT)
- +4 more
-
Palo Alto, CaliforniaStanford University
Dec 8, 2021
Cardiovascular Abnormalities Trial in Plano (FFRct and SPECT)
Active, not recruiting
- Cardiovascular Abnormalities
- FFRct and SPECT
-
Plano, TexasThe Heart Hospital Baylor Plano
Mar 7, 2022
Depression Trial in Brétigny-sur-Orge, Marseille (other, device, biological)
Not yet recruiting
- Depression
- Physical training
- +3 more
-
Brétigny-sur-Orge, France
- +2 more
Aug 26, 2021
Myelodysplastic Syndrome, Previously Treated Myelodysplastic Syndrome, Recurrent Adult Acute Myeloid Leukemia Trial in
Recruiting
- Myelodysplastic Syndrome
- +16 more
- Computed Tomography
- +6 more
-
Scottsdale, Arizona
- +2 more
Feb 3, 2022
Head Neck Cancer Trial in Stanford (111I-n panitumumab, Single photon emission computed tomography/computed tomography
Recruiting
- Head and Neck Cancer
- 111I-n panitumumab
- Single photon emission computed tomography/computed tomography (SPECT/CT) scans
-
Stanford, CaliforniaStanford University
Mar 11, 2022
Mechanisms of Resistance to PSMA Radioligand Therapy
Recruiting
- Prostate Cancer
- Single-photon emission computed tomography
- +2 more
-
Los Angeles, California
- +2 more
Jun 22, 2022
Pulmonary Embolism Trial in France, Switzerland (Planar V/Q-based strategy, CTPA-based strategy, V/Q SPECT-based strategy)
Recruiting
- Pulmonary Embolism
- Planar V/Q-based strategy
- +2 more
-
Agen, France
- +11 more
Jul 20, 2021
Parkinsonian Syndrome, Parkinson Disease(PD), Multiple System Atrophy (MSA) Trial in China (DaTSCAN™ Ioflupane (123I) Injection)
Completed
- Parkinsonian Syndrome
- +3 more
- DaTSCAN™ Ioflupane (123I) Injection
-
Beijing, Chaoyang District, China
- +9 more
Jun 20, 2022